191 related articles for article (PubMed ID: 33849437)
1. Relationship between body composition and the histology of non-alcoholic fatty liver disease: a cross-sectional study.
Miyake T; Miyazaki M; Yoshida O; Kanzaki S; Nakaguchi H; Nakamura Y; Watanabe T; Yamamoto Y; Koizumi Y; Tokumoto Y; Hirooka M; Furukawa S; Takeshita E; Kumagi T; Ikeda Y; Abe M; Toshimitsu K; Matsuura B; Hiasa Y
BMC Gastroenterol; 2021 Apr; 21(1):170. PubMed ID: 33849437
[TBL] [Abstract][Full Text] [Related]
2. Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease.
Shida T; Akiyama K; Oh S; Sawai A; Isobe T; Okamoto Y; Ishige K; Mizokami Y; Yamagata K; Onizawa K; Tanaka H; Iijima H; Shoda J
J Gastroenterol; 2018 Apr; 53(4):535-547. PubMed ID: 28791501
[TBL] [Abstract][Full Text] [Related]
3. Sex influences the association between appendicular skeletal muscle mass to visceral fat area ratio and non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease.
Li G; Rios RS; Wang XX; Yu Y; Zheng KI; Huang OY; Tang LJ; Ma HL; Jin Y; Targher G; Byrne CD; Pan XY; Zheng MH
Br J Nutr; 2022 Jun; 127(11):1613-1620. PubMed ID: 34176541
[TBL] [Abstract][Full Text] [Related]
4. Sex- and reproductive status-specific relationships between body composition and non-alcoholic fatty liver disease.
Cao YT; Zhang WH; Lou Y; Yan QH; Zhang YJ; Qi F; Xiang LL; Lv TS; Fang ZY; Yu JY; Zhou XQ
BMC Gastroenterol; 2023 Oct; 23(1):364. PubMed ID: 37875811
[TBL] [Abstract][Full Text] [Related]
5. Association of low skeletal muscle mass with advanced liver fibrosis in patients with non-alcoholic fatty liver disease.
Kang MK; Park JG; Lee HJ; Kim MC
J Gastroenterol Hepatol; 2019 Sep; 34(9):1633-1640. PubMed ID: 30667551
[TBL] [Abstract][Full Text] [Related]
6. The relationship between non-alcoholic fatty liver and skeletal muscle mass to visceral fat area ratio in women with type 2 diabetes.
Su X; Xu J; Zheng C
BMC Endocr Disord; 2019 Jul; 19(1):76. PubMed ID: 31315613
[TBL] [Abstract][Full Text] [Related]
7. Predictors of nonalcoholic steatohepatitis and significant fibrosis in non-obese nonalcoholic fatty liver disease.
Kim D; Kim W; Joo SK; Kim JH; Harrison SA; Younossi ZM; Ahmed A
Liver Int; 2019 Feb; 39(2):332-341. PubMed ID: 30298568
[TBL] [Abstract][Full Text] [Related]
8. Preperitoneal fat as a non-invasive marker of increased risk of severe non-alcoholic fatty liver disease in patients with type 2 diabetes.
Parente DB; Oliveira Neto JA; Brasil PEAA; Paiva FF; Ravani JPR; Gomes MB; Lanzoni V; Campos CFF; Machado-Silva L; Perez RM; Rodrigues RS
J Gastroenterol Hepatol; 2018 Feb; 33(2):511-517. PubMed ID: 28726335
[TBL] [Abstract][Full Text] [Related]
9. The relationship between skeletal muscle mass to visceral fat area ratio and metabolic dysfunction-associated fatty liver disease subtypes in middle-aged and elderly population: a single-center retrospective study.
Xing M; Ni Y; Zhang Y; Zhao X; Yu X
Front Nutr; 2023; 10():1246157. PubMed ID: 38024359
[TBL] [Abstract][Full Text] [Related]
10. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.
Koo BK; Kim D; Joo SK; Kim JH; Chang MS; Kim BG; Lee KL; Kim W
J Hepatol; 2017 Jan; 66(1):123-131. PubMed ID: 27599824
[TBL] [Abstract][Full Text] [Related]
11. Estimation of visceral fat is useful for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease.
Hernández-Conde M; Llop E; Carrillo CF; Tormo B; Abad J; Rodriguez L; Perelló C; Gomez ML; Martínez-Porras JL; Puga NF; Trapero-Marugan M; Fraga E; Aracil CF; Panero JLC
World J Gastroenterol; 2020 Nov; 26(42):6658-6668. PubMed ID: 33268953
[TBL] [Abstract][Full Text] [Related]
12. The Correlation Between Body Fat, Visceral Fat, and Nonalcoholic Fatty Liver Disease.
Ko YH; Wong TC; Hsu YY; Kuo KL; Yang SH
Metab Syndr Relat Disord; 2017 Aug; 15(6):304-311. PubMed ID: 28481662
[TBL] [Abstract][Full Text] [Related]
13. Advanced fibrosis of non-alcoholic steatohepatitis affects the significance of lipoprotein(a) as a cardiovascular risk factor.
Konishi K; Miyake T; Furukawa S; Senba H; Kanzaki S; Nakaguchi H; Yukimoto A; Nakamura Y; Watanabe T; Koizumi Y; Yoshida O; Tokumoto Y; Hirooka M; Kumagi T; Abe M; Matsuura B; Hiasa Y
Atherosclerosis; 2020 Apr; 299():32-37. PubMed ID: 32203743
[TBL] [Abstract][Full Text] [Related]
14. What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?
Machado MV; Policarpo S; Coutinho J; Carvalhana S; Leitão J; Carvalho A; Silva AP; Velasco F; Medeiros I; Alves AC; Bourbon M; Cortez-Pinto H
Obes Surg; 2020 Feb; 30(2):560-568. PubMed ID: 31637670
[TBL] [Abstract][Full Text] [Related]
15. Visceral adiposity as a risk factor for lean non-alcoholic fatty liver disease in potential living liver donors.
Lee S; Kim KW; Lee J; Park T; Khang S; Jeong H; Song GW; Lee SG
J Gastroenterol Hepatol; 2021 Nov; 36(11):3212-3218. PubMed ID: 34169561
[TBL] [Abstract][Full Text] [Related]
16. The Leg Fat to Total Fat Ratio Is Associated with Lower Risks of Non-Alcoholic Fatty Liver Disease and Less Severe Hepatic Fibrosis: Results from Nationwide Surveys (KNHANES 2008-2011).
Kim HM; Lee YH
Endocrinol Metab (Seoul); 2021 Dec; 36(6):1232-1242. PubMed ID: 34809412
[TBL] [Abstract][Full Text] [Related]
17. Cancer-related gene expression is associated with disease severity and modifiable lifestyle factors in non-alcoholic fatty liver disease.
Arendt BM; Teterina A; Pettinelli P; Comelli EM; Ma DWL; Fung SK; McGilvray ID; Fischer SE; Allard JP
Nutrition; 2019 Jun; 62():100-107. PubMed ID: 30870804
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Computed Tomography-based Abdominal Adiposity Indexes as Predictors of Non-alcoholic Fatty Liver Disease Among Middle-aged Korean Men and Women.
Baek J; Jung SJ; Shim JS; Jeon YW; Seo E; Kim HC
J Prev Med Public Health; 2020 Jul; 53(4):256-265. PubMed ID: 32752595
[TBL] [Abstract][Full Text] [Related]
19. Body fat distribution and risk factors for fibrosis in patients with alcoholic liver disease.
Naveau S; Dobrin AS; Balian A; Njiké-Nakseu M; Nohra P; Asnacios A; Prévot S; Perlemuter G
Alcohol Clin Exp Res; 2013 Feb; 37(2):332-8. PubMed ID: 22958117
[TBL] [Abstract][Full Text] [Related]
20. Impedance-based measures of muscle mass can be used to predict severity of hepatic steatosis in pediatric nonalcoholic fatty liver disease.
Yodoshi T; Orkin S; Romantic E; Hitchcock K; Clachar AA; Bramlage K; Sun Q; Fei L; Trout AT; Xanthakos SA; Mouzaki M
Nutrition; 2021; 91-92():111447. PubMed ID: 34583137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
